期刊文献+

N-三甲基壳聚糖包衣的维生素A棕榈酸酯脂质体的制备及其体外释药 被引量:5

Study on the preparation of vitamin A palmitate liposomes coated by N-trimethyl chitosan and their drug release characteristic in vitro
原文传递
导出
摘要 目的:研制N-三甲基壳聚糖(TMC)包衣的维生素A棕榈酸酯脂质体(VAPL),并对其进行体外释药考察。方法:采用薄膜分散法制备VAPL,合成不同季铵化程度的TMC,并对VAPL进行包衣。以包封率为指标,筛选VAPL最佳处方;用透析法进行体外释药研究。结果:最优处方的TMC包衣VAPL平均包封率为(85.2±3.2)%(n=3)。未包衣VAPL平均粒径为(97.20±0.09)nm,Zeta电位为(-49.1±0.7)mV。TMC包衣后,随着TMC季铵化程度的增大,Zeta电位显著增大(P<0.05);TMC20、TMC40、TMC60包衣脂质体体外释药曲线符合Higuchi方程,分别为Q=4.3408t1/2+4.2295(r=0.9552),Q=4.1116t1/2+3.6312(r=0.9601),Q=3.3418t1/2+3.9545(r=0.9546)。结论:TMC包衣VAPL的制备工艺可行,其表面带有较高正电性,为下一步研究延长角膜滞留时间的释药系统打下基础。 OBJECTIVE To prepare vitamin A palmitate liposomes (VAPL) coated by N-trimethyl chitosan (TMC) and study on their drug release characteristic in vitro. METHODS VAPL were prepared by the film dispersion method. TMCs with different degree of quarternization (DO) were used to coat the liposomes. The encapsulation efficiency was chosen as the index to screen the optimal formulation of the preparation. Dialyzer was employed to study the release of VAP from the liposomes in vitro. RESULTS The mean entrapment efficiency of optimal TMC coated VAPL formulation was (85.2 ± 3.2)% (n = 3). The mean diameter of VAPL before coating was (97.20 ± 0. 09)nm,and the zeta potential was ( - 49. 1 ± 0. 7)mV. As the increase of DQ of TMC, the zeta potential of TMC-coated VAPL was increased significantly (P〈0. 05). The VAP release from TMC20,TMC40 and TMC60 - coated VAPL in vitro was accorded with the following Higuchi equation, respectively: Q =4.3408t^1/2+4.2295(r=0.9552),Q=4.111 6t^1/2+3.6312(r=0.9601) and Q=3.341 8t^1/2 +3.9545(r=0.9546). CONCLUSION The preparation of VAPI. coated by different DQ of TMC was feasible. Their positive zeta potential was the basis of the further study on drug release system to prolong corneal retention time.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2010年第11期921-925,共5页 Chinese Journal of Hospital Pharmacy
关键词 N-三甲基壳聚糖 维生素A棕榈酸酯 脂质体 包衣 体外释药 N-trimethyl chitosan vitamin A palmitate liposomes coating release in vitro
  • 相关文献

参考文献11

二级参考文献21

  • 1饶泽青,门智明.高效液相色谱法同时测定强化食品中的维生素A、D、E[J].营养学报,1994,16(1):83-88. 被引量:16
  • 2隋因,刘宝庆,夏东亚.冷冻干燥法制备阿糖胞苷冻干脂质体粉针研究[J].中国医院药学杂志,1995,15(11):487-490. 被引量:17
  • 3Verkman AS,Talda R, Sefton B, et al. Quantitative fluorescence measurement of chloride transport mechanisms in phospholipid vesicles[ J ]. Biochemistry, 1989,28 (10) : 4240.
  • 4Rao US, Hennessey JP Jr, Scarborough GA. Identification of the membrane-embedded regions of the Neurospora crassa plasma membrane H( + )-ATPase[J ]. J Biol Chem, 1991,266(22):14740.
  • 5Harrington KJ, Rowlinson-Busza G, Syrigos KN. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies [J]. Br J Cancer, 2000,83(2):232-238.
  • 6Sihorkar V, Vyas SP. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization [J]. J Pharm Sci, 2001,4(2):138-158.
  • 7Budai M, Szogyi M. Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes [J]. Acta Pharm Hung, 2001,71(1):114-118.
  • 8Edwards C. Physiology of the colorectal barrier [J]. Adv Drug Deliv Rev, 1997,28:173-190.
  • 9Roger CC. New Liposomes: a Practice Approach [M]. Oxford: Oxford University Press, 1994.108-109.
  • 10Schreiber AB, Haimovich J. Quantitative fluorometric assay for detection and characterization of Fc receptor [J]. Methods Enzymol, 1983,93:147-155.

共引文献169

同被引文献60

  • 1高斐,王东凯,罗立,徐松林,刘莱,徐飒.左氧氟沙星热敏型眼用凝胶的研制及体外释放研究[J].中国药房,2005,16(14):1057-1059. 被引量:42
  • 2沈佐莲,吕光,李蓉.司帕沙星滴眼液的药效学实验研究[J].中国药业,2005,14(9):31-31. 被引量:9
  • 3吴小妹,张鸿炼.盐酸左氧氟沙星眼用凝胶对家兔眼刺激性试验[J].现代医药卫生,2006,22(4):604-605. 被引量:4
  • 4张翠霞,张文涛,王东凯,仲静洁,徐飒.新型的药物传递系统-原位凝胶的研究进展[J].中国医院药学杂志,2006,26(4):459-461. 被引量:42
  • 5侯振清 张镇西.胰岛素制剂的历史演变及发展状况[J].中华医药杂志,2004,4(7):619-622.
  • 6Meisner D, Mezei M. Liposome ocular delivery systems [ J ]. Adv Drug Deliv Rev , 1995,16:75-93.
  • 7Rabinovich-Guilatt L, Couvreur P, et al. Cationic vectors in ocular drug delivery. [ J ]. J DrugTarget, 2004,12 ( 9 -10 ) : 623-633.
  • 8Cortesi R, Arguani R, Esposito E,et al. Cationic liposomes as potential carriers for ocular administration of pep tides with anti2herpetic activity [J]. lnt J Pharm,2006,317( 1 ) :90-100.
  • 9Spyridon M, Styliani F, Stela D, et al. Liposomal drugs dispersed in hydrogels effect of liposome, drug and gel properties on drug release kinetics [ J]. Coll Surf B Biointerfaces ,2007,55 (2) :212-221.
  • 10Desai SD, Blanchard J. In vitro evaluation of pluronic F127-based controlled release ocular delivery systems for pilocarp ine [ J ]. J Pharm Sci, 1998,87 ( 2 ) : 226 -230.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部